Trimethoprim use before pregnancy and risk of congenital malformation: Reanalyzed using a case-crossover design and a case-time-control design

Pharmacoepidemiology and Drug Safety

Volumn 23, Issue 10, 2014, Pages 1076-1083

  Sun, Yuelian ^a,c   Wu, Chun Sen ^a   Olsen, Jørn ^a,b  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (Denmark)

Author keywords

Antibiotics; Case crossover design; Case time control design; Congenital malformation; Pharmacoepidemiology; Trimethoprim

Indexed keywords

TRIMETHOPRIM;

ABNORMALITIES, DRUG-INDUCED; CASE CONTROL STUDY; CHEMICALLY INDUCED; CROSSOVER PROCEDURE; DENMARK; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; NEWBORN; PREGNANCY; PRENATAL EXPOSURE;

ABNORMALITIES, DRUG-INDUCED; CASE-CONTROL STUDIES; CROSS-OVER STUDIES; DENMARK; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TRIMETHOPRIM;

EID: 84911362076     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3691     Document Type: Article

References (27)

1. Schneeweiss S, Stürmer T, Maclure M. Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf 1997; 6(Suppl 3): S51-S59.
2. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991; 133: 144-153.
3. Feldmann U. Epidemiologic assessment of risks of adverse reactions associated with intermittent exposure. Biometrics 1993; 49: 419-428.
4. Suissa S. The case-time-control design. Epidemiology 1995; 6: 248-253.
5. Suissa S. The case-time-control design: further assumptions and conditions. Epidemiology 1998; 9: 441-445.
6. Smulders YM, de Man AM, Stehouwer CD, Slaats EH. Trimethoprim and fasting plasma homocysteine. Lancet 1998; 352: 1827-1828.
7. Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000; 343: 1608-1614.
8. Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 2001; 153: 961-968.
9. Andersen JT, Petersen M, Jimenez-Solem E, et al. Trimethoprim use prior to pregnancy and the risk of congenital malformation: a register-based nationwide cohort study. Obstet Gynecol Int 2013; 2013: Epub, article id: 364526.
10. Gaist D, Sørensen HT, Hallas J. The Danish prescription registries. Dan Med Bull 1997; 44: 445-448.
11. Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health 2011; 39: 38-41.
12. Andersen TF, Madsen M, Jørgensen J, Mellemkjær L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263-268.
13. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull 1998; 45: 320-323.
14. Hernández-Díaz S, Hernán MA, Meyer K, Werler MM, Mitchell AA. Case-crossover and case-time-control designs in birth defects epidemiology. Am J Epidemiol 2003; 158: 385-391.
15. Miller JE, Pedersen LH, Sun Y, Olsen J. Maternal use of cystitis medication and childhood epilepsy in a Danish population-based cohort. Paediatr Perinat Epidemiol 2012; 26: 589-595.
16. Nicholas JM, Grieve AP, Gulliford MC. Within-person study designs had lower precision and greater susceptibility to bias because of trends in exposure than cohort and nested case-control designs. J Clin Epidemiol 2012; 65: 384-393.
17. Maclure M, Mittleman MA. Should we use a case-crossover design? Annu Rev Public Health 2000; 21: 193-221.
18. Greenland S. The effect of misclassification in matched-pair case-control studies. Am J Epidemiol 1982; 116: 402-406.
19. Greenland S. Confounding and exposure trends in case-crossover and case-time-control designs. Epidemiology 1996; 7: 231-239.
20. Dosedla E, Kalafusová M, Calda P. Sirenomelia apus after trimethoprim exposure: first-trimester ultrasound diagnosis-a case report. J Clin Ultrasound 2012; 40: 594-597.
21. Czeizel AE, Rockenbauer M, Sørensen HT, Olsen J. The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study. Reprod Toxicol 2001; 15: 637-646.
22. Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sørensen HT. Recall bias in a case-control surveillance system on the use of medicine during pregnancy. Epidemiology 2001; 12: 461-466.
23. Greenland S. A unified approach to the analysis of case-distribution (case-only) studies. Stat Med 1999; 18: 1-15.
24. Lipsitch M, Tchetgen TE, Cohen T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology 2010; 21: 383-388.
25. Hak E, Verheij TJ, Grobbee DE, Nichol KL, Hoes AW. Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications. J Epidemiol Community Health 2002; 56: 951-955.
26. Signorello LB, McLaughlin JK, Lipworth L, Friis S, Sørensen HT, Blot WJ. Confounding by indication in epidemiologic studies of commonly used analgesics. Am J Ther 2002; 9: 199-205.
27. Kjær D, Horvath-Puhó E, Christensen J, et al. Use of phenytoin, phenobarbital, or diazepam during pregnancy and risk of congenital abnormalities: a case-time-control study. Pharmacoepidemiol Drug Saf 2007; 16: 181-188.